Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2011 | 10-2010 | 07-2010 | 04-2010 | 01-2010 | |
| Sales | 2,805 | 933 | 1,600 | 1,900 | 742 |
| Cost of Goods | 1,413 | 559 | 546 | 546 | 364 |
| Gross Profit | 1,392 | 374 | 1,054 | 1,354 | 378 |
| Operating Expenses | 2,591 | 1,948 | 2,203 | 2,452 | 1,526 |
| Operating Income | -786 | -1,015 | -603 | -552 | -784 |
| Other Income | 371 | 961 | 12 | 0 | 0 |
| Pre-tax Income | -415 | -54 | -591 | -552 | -784 |
| Net Income Continuous | -415 | -54 | -591 | -552 | -784 |
| Net Income | $-415 | $-54 | $-591 | $-552 | $-784 |
| EPS Basic Total Ops | -0.12 | 0.00 | -0.24 | -0.24 | -0.24 |
| EPS Basic Continuous Ops | -0.14 | -0.02 | -0.21 | -0.18 | -0.28 |
| EPS Diluted Total Ops | -0.12 | 0.00 | -0.24 | -0.24 | -0.24 |
| EPS Diluted Continuous Ops | -0.14 | -0.02 | -0.21 | -0.18 | -0.28 |
| EBITDA(a) | $-776 | $-1,005 | $-593 | $-544 | $-776 |